A decision analysis model for colorectal cancer screening

Daniel Corrales, David Ríos Insua, Marino J. González · 2025

Read A decision analysis model for colorectal cancer screening by Daniel Corrales, David Ríos Insua, Marino J. González (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2502-21210.txt.

Introduction

Daniel Corrales, David Ríos Insua, and Marino González built in 2025 a decision model to personalize colorectal cancer screening. Most European programs screen by age alone, with one rule for everyone. Their model weighs a person's risk factors alongside comfort, costs, complications, and the value of information gained. A multi-attribute utility framework combines these into recommended policies.

The tool can judge whether to screen, which test to use, and whether to proceed to colonoscopy for a given individual. It can also evaluate existing national programs and help design new ones. The authors argue personalized strategies should replace purely age-based ones. The framework additionally lets planners benchmark novel screening devices before adoption.

Catalog record

CREATORDaniel Corrales, David Ríos Insua, Marino J. González
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2502-21210

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A decision analysis model for colorectal cancer screening Daniel Corrales, David Ríos Insua, Marino J. González Abstract Background and Objective With minor differences, most national colorectal cancer (CRC) screening programs in Europe consist of one-size-fits-all aged-based strategies. This paper provides a decision analysis-based approach to personalized CRC screening, supporting decisions concerning whether and which screening method to consider and/or whether a colonoscopy should be administered. Methods We use an influence diagram which characterizes CRC risk with respect to different variables of interest and includes comfort, costs, complications, and information as decision criteria, the last one assessed through information theory measures. The criteria are integrated with a multi-attribute utility model. Optimal screening policies are then computed. Results The proposed model is used to support personalized individual screening based on relevant characteristics. It serves to assess existing national screening programs and design new ones. In particular, it suggests replacing current age-based strategies followed in many European countries by more personalized strategies based on the type of model proposed. Additionally, the model facilitates benchmarking of novel screening devices. Conclusions This work creates a framework supporting personalized CRC screening improving upon current age-based screening strategies. 1 Introduction Although colorectal cancer (CRC) is the third most common type of cancer worldwide, making up for about 10 % of all cases, only about 14 % of susceptible EU citizens participate in CRC screening programs. At the moment, these are mainly one-size-fits-all strategies [ 1 ] focused on age and using fecal testing and colonoscopy (CS). The latter is considered highly invasive, influencing quite negatively program uptake among the general population [ 2 ] . It has been reported [ 3 ] through the European Health Interview Survey (2018-2020) that the coverage of faecal tests in the population aged 50-74 varies according to the organisation of the screening programme. In countries with fully rolled-out programmes it varies from 37.7% in Croatia to 74.9% in Denmark; in turn, in countries without programmes or with localised programmes it varies from 6.3% in Bulgaria to 34.2% in Latvia. This study also found statistical evidence that less participation in screening programmes corresponds to unmarried adult patients which have a low educational level, live in rural areas, have an unhealthy lifestyle or spend long periods without health checks. Hence, on the one hand, there is a clear need for accurate, non-invasive, cost-effective screening tests using novel technologies as well as, on the other, for raising awareness about the disease and its early detection. In addition, genetic, socioeconomic, and behavioral factors can influence the development of CRC and lead to different disease onsets. Recent studies [ 4 ] show that early-onset CRC incidence is rising in several countries, pointing at some of the mentioned risk factors as potential causes. Personalized screening strategies that consider these factors seem relevant together with decision tools with guarantees that support experts in their implementation. This is especially important given the discrepancies among the strategies implemented in different countries [ 5 ] . As an example, in 2013 the European Union (EU) drafted guidelines for quality assurance in CRC screening and diagnosis, recommending the use of national programs based on fecal immunochemical tests (FIT) and CS [ 6 ] . Such guidelines suggested that the identification and invitation of the target population, diagnosis and management of the disease, and the appropriate surveillance of people with detected lesions could be achieved by following and adopting the proposed recommendations. Interestingly, though the screening program structure is similar across many countries, details such as age or test cutoffs differ [ 7 ] . In Western Europe, most programs are regional or national and based on FIT or gFOBT (guiac fecal occult blood test), with wide differences in participation rates. In Eastern Europe, countries mostly rely on pilot or opportunistic programs, also based on FIT or gFOBT, with lower participation rates. Relevant analyses have been developed to assess the importance of various factors influencing the effectiveness of CRC screening programs. A significant portion of the work in the field is dedicated to applying Markov models for cost-effectiveness analyses of screening [ 8 ] , or to modeling patients’ preferences concerning screening methods taking into account their risk tolerance [ 9 ] . An important and complementary approach to further improve the evaluation of program needs, effectiveness, and objectives is the development of CRC predictive models that form the foundation of decision-support tools for screening. In particular, Bayesian Networks (BNs) [ 10 ] are used to infer the influence that certain risk factors can have on CRC and how they could affect the decisions made by policymakers. Influence Diagrams (IDs) [ 11 ] extend BNs by incorporating decision nodes and utility variables to support multiple criteria decisions under uncertainty. These analyses have proved to be relevant in medical decision-making [ 12 , 13 ] . This paper constructs a decision support model that serves to benchmark CRC screening programs, among other uses. We draw upon earlier work on CRC risk assessment through BNs [ 14 ] and complement it to design an ID that identifies the screening methods adopted, their impacts, and their associated utilities. It will be used to discuss relevant policy questions concerning CRC screening. For this, Section 2 defines how the problem is structured and present the underlying prediction and preference models. After that, Section 3 describes a set of important use cases including supporting personalized screening decisions, assessing national screening strategies, designing such strategies, and specifying benchmarks for novel screening technologies. Software supporting the proposed approach produced in GeNIe [ 15 ] and its Python wrapper PySMILE is available at [ 16 ] for reproducibility purposes. 2 Methods 2.1 CRC screening decision problem structure This section describes the structure of our CRC personalized screening decision support model. 2.1.1 CRC underlying predictive model Our model relies on a BN predictive model previously developed for CRC risk mapping purposes [ 14 ] . The BN aggregates exhaustive expert information and data from a large occupational health assessment study. It relates modifiable (physical activity, sleep duration, alcohol consumption, smoking status, body mass index (BMI), anxiety, depression) and non-modifiable (sex, age, socio-economic status) risk factors as well as medical conditions (hypercholesterolemia, hypertension, diabetes) relevant to CRC, assessing such relations through local probability distributions at the nodes. Figure 1 presents the original BN, with variables in different colors depending on whether they refer to non-modifiable (green) or modifiable (red) risk factors, medical conditions (blue), or the CRC target (purple) variable. Black arrows were initially elicited from expert information, whereas red arrows were discovered and incorporated using a large database of annual occupational health assessments (2M people). Procedures to assess the probability tables and the BN use for risk mapping and influential variable detection are detailed in [ 14 ] . Figure 1 : Originating CRC Bayesian Network [ 14 ] 2.1.2 CRC screening decision model For the construction of the ID for the CRC screening decision-support problem, a set of variables (chance, decision, and values) are defined and incorporated, together with the corresponding arcs, into the original BN. \subsubsubsection *Hypotheses Before presenting the variables, let us first introduce four hypotheses used in constructing the model. 1. Rather than the prevalent one-size-fits-all strategies [ 1

Read the complete text